To Download a copy of the presentation click here.
Presented in partnership with the American Academy of Pediatrics and the Pediatrics Infectious Diseases Society.
*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.
These one-hour webinars, held Saturdays at 3 p.m. ET, focus on timely issues of relevance to clinicians and feature case presentations by experts in the field, synthesis of new data, and an opportunity to engage with colleagues. Register for next week here.
Moderator:
Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA
Topics and Featured Experts:
The Development of COVID-19 Vaccines
• Peter Marks, MD, PhD
Director
Center for Biologics Evaluation and Research
U.S. Food and Drug Administration
Clinical Considerations for Pfizer-BioNTech COVID-19 Vaccination in Adolescents
• Kate R. Woodworth, MD, MPH
COVID-19 Response, Clinical Guidelines Team, Vaccine Task Force
U.S. Centers for Disease Control and Prevention
• Sarah Mbaeyi, MD, MPH
Chief Medical Officer, COVID-19 Vaccine Task Force
U.S. Centers for Disease Control and Prevention
Community Vaccine Implementation for Adolescents
• Lee Ann Savio Beers, MD, FAAP
President, American Academy of Pediatrics
Professor of Pediatrics and Medical Director for Community Health and Advocacy
Children’s National Hospital
SARS-CoV-2 Vaccines in Children and Adolescents: Implications for the Future
• Janet A. Englund, MD
Professor of Pediatrics
University of Washington
Director of Transplant ID
Division of Pediatric Infectious Diseases
Seattle Children's Hospital
